carbostyril has been researched along with Thrombosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hidaka, H; Inoue, Y; Kihara, Y; Kimura, Y; Koga, Y; Nishi, T; Okada, M; Tachibana, K; Tochizawa, S; Toga, K | 1 |
Yasunaga, K | 1 |
Brassard, CL; Buchanan, JO; Dennis, RD; Gamberdella, M; Gillespie, E; Meanwell, NA; Rosenfeld, MJ; Roth, HR; Smith, EC; Wright, JJ | 1 |
3 other study(ies) available for carbostyril and Thrombosis
Article | Year |
---|---|
2(1H)-quinolinone derivatives as novel anti-arteriostenotic agents showing anti-thrombotic and anti-hyperplastic activities.
Topics: Animals; Arteriosclerosis; Cilostazol; Hyperplasia; Platelet Aggregation Inhibitors; Quinolines; Quinolones; Rabbits; Tetrazoles; Thrombosis; Urea | 1998 |
[Inhibition of platelet aggregation by platelet inhibitory agents and its relation to their clinical effects].
Topics: Depression, Chemical; Dipyridamole; Dose-Response Relationship, Drug; Humans; Phthalazines; Platelet Aggregation; Pyridazines; Quinolines; Quinolones; Sulfinpyrazone; Thrombosis | 1979 |
Inhibitors of blood platelet cAMP phosphodiesterase. 3. 1,3-Dihydro-2H-imidazo[4,5-b]quinolin-2-one derivatives with enhanced aqueous solubility.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Blood Platelets; Humans; Imidazoles; Quinolones; Rabbits; Solubility; Thrombosis | 1992 |